Nicole Saphier’s Anti-Nicotine Pouch Stance Raises Concerns Over Harm Reduction Policy

During a Senate confirmation hearing in January 2025, Secretary of Health and Human Services Robert F. Kennedy Jr. appeared to place a nicotine pouch between his lower lip and gums, replacing a used one. Nicole Saphier, the radiologist and Fox News contributor nominated by President Donald Trump as surgeon general last Thursday, publicly condemned the act.

In a New York Post op-ed published after the hearing, Saphier expressed her disapproval, signaling her opposition to tobacco harm reduction strategies. She wrote:

"After decades of relentless public health campaigns and advocacy against cigarette smoking, we are witnessing the tangible benefits, with [declines in] smoking rates and the illnesses associated with [smoking]. But as we relish this good news, the rise of nicotine pouches could upend this great advancement in public health."

Saphier’s argument, however, contains two critical inaccuracies. First, she downplayed the stark difference in health risks between nicotine pouches and cigarettes. Second, she overlooked the role pouches can play in advancing public health by providing adult smokers with a less hazardous alternative.

The Food and Drug Administration (FDA) recognized the harm-reducing potential of nicotine pouches in late 2024, authorizing the marketing of Zyn nicotine pouches in two doses and 10 flavors. The FDA’s decision was based on evidence that these products "offer greater benefits to population health than risks."

Matthew Farrelly, director of the Office of Science at the FDA’s Center for Tobacco Products, stated that the data "show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products."

The FDA noted that nicotine pouches contain "substantially lower amounts of harmful constituents than cigarettes," making them "a lower-risk alternative for adults who smoke cigarettes."

Despite this scientific consensus, Saphier dismissed the health advantages of nicotine pouches. She argued they are marketed "under the pretext that they are a safer alternative to traditional cigarettes." She also expressed concern that social media influencers promote them as "tobacco-free, smoke-free and odorless," which she claimed appeals to younger Americans.

In reality, nicotine pouches are a safer alternative to traditional cigarettes, as the FDA has acknowledged. They are also indisputably tobacco-free and smoke-free, meaning their use does not expose users to the toxins and carcinogens produced by tobacco combustion.

Saphier’s characterization of these benefits as illusory or a marketing tactic contradicts the FDA’s findings. She wrote:

"The FDA has authorized Zyn and other pouches as a smoking reduction aid, giving them a reputation as a less harmful alternative."